FDA Brief

Warning letters Drugs

FDA warning letter to

AcelRx Pharmaceuticals, Inc.

Issued Feb 11, 2021Posted Feb 16, 2021The Office of Prescription Drug Promotion (OPDP)

False & Misleading Claims/Misbranded. We haven't summarized this letter yet. Read it on fda.gov.